12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·09/02/2025 17:06:49
Listen to the news
Gainers
- CARISMA Therapeutics (NASDAQ:CARM) shares increased by 108.5% to $0.45 during Tuesday's regular session. The market value of their outstanding shares is at $8.9 million.
- Mineralys Therapeutics (NASDAQ:MLYS) shares rose 86.36% to $28.85. The company's market cap stands at $1.0 billion.
- Cytokinetics (NASDAQ:CYTK) stock rose 39.0% to $49.11. The company's market cap stands at $4.2 billion.
- United Therapeutics (NASDAQ:UTHR) stock rose 34.82% to $410.88. The company's market cap stands at $13.7 billion.
- Ionis Pharmaceuticals (NASDAQ:IONS) shares moved upwards by 32.66% to $56.56. The company's market cap stands at $6.7 billion.
- Relmada Therapeutics (NASDAQ:RLMD) shares moved upwards by 25.89% to $1.41. The company's market cap stands at $37.1 million.
Losers
- Celularity (NASDAQ:CELU) shares fell 36.0% to $2.52 during Tuesday's regular session. The market value of their outstanding shares is at $94.3 million. As per the press release, Q2 earnings came out 2 days ago.
- Tectonic Therapeutic (NASDAQ:TECX) stock decreased by 32.52% to $17.24. The market value of their outstanding shares is at $477.9 million.
- ALT5 Sigma (NASDAQ:ALTS) stock decreased by 28.88% to $5.61. The company's market cap stands at $958.2 million.
- Purple Biotech (NASDAQ:PPBT) shares decreased by 23.87% to $1.51. The market value of their outstanding shares is at $5.2 million.
- ImmunoPrecise Antibodies (NASDAQ:IPA) shares declined by 18.57% to $1.93. The market value of their outstanding shares is at $109.3 million.
- Canopy Growth (NASDAQ:CGC) stock fell 15.9% to $1.51. The market value of their outstanding shares is at $561.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.